Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine Fumarate for Postoperative Analgesia After Orthopedic Surgery
NCT07353996Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tegileridine in postoperative pain, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Effective dose producing adequate postoperative analgesia in 90% of patients. Started Oct 2025; status: recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07353996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07353996.